US Biosimilars Market Is On Solid Footing, 10 Years In
BIO 2020 Panelists Agree Momentum Is Building
The market for biosimilars in the US appears to be improving, industry leaders said during a panel on biosimilars at the BIO 2020 digital meeting.
The market for biosimilars in the US appears to be improving, industry leaders said during a panel on biosimilars at the BIO 2020 digital meeting.